Featured Lecture: How to Incorporate New Therapies and In What Order -- Ahead of the Guidelines

Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of patients with any cardiovascular disease to include devices, drugs, and digital health care products listed below:

• Consultant Fee/Honoraria/Speaker's Bureau - AstraZenca; Amgen; Boehringer Ingelheim; Cardiorentis; Daiichi Sankyo; Actavis; Johnson & Johnson; Pfizer; Relypsa; Synthetic Biologics; Theravance
• Grant Support/Research Contract - Abbvie